Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Vanessa Carranza"'
Publikováno v:
Cancer Research. 81:PS9-65
Background:We evaluated the effect of this virtual education on knowledge, competence, and performance in oncology pharmacists who participated in a virtual symposium held during the Hematology/Oncology Pharmacy Association Annual Conference. The edu
Publikováno v:
Journal of Clinical Oncology. 40:e23003-e23003
e23003 Background: About 35% of ovarian cancer patients in the US have geographic-related disparities in their access to gynecologic oncologists. This disparity becomes more apparent as advances in the treatment of ovarian cancer continues to improve
Autor:
Bryan Carson Taylor, George M. Rodgers, Susan H. Gitzinger, Tina Trieu, Vanessa Carranza, Jessica Hall, Rebecca Weaver
Publikováno v:
Journal of Clinical Oncology. 40:e23001-e23001
e23001 Background: Anemia is an extremely common and robustly deleterious complication experienced by patients with cancer, with impacts ranging from patient-reported quality-of-life metrics, to functional capacity, to morbidity and mortality implica
Autor:
Susan H. Gitzinger, Bryan Carson Taylor, Vanessa Carranza, Joan B. Fowler, Tina Trieu, Ashley Lilly
Publikováno v:
Journal of Clinical Oncology. 40:e23002-e23002
e23002 Background: There are an estimated >81,000 new cases of metastatic urothelial bladder cancer (mUBC) diagnosed in the U.S each year, resulting in more than 17,000 deaths. mUBC has been shown to be susceptible to immune checkpoint inhibitors (IC
Publikováno v:
Blood. 136:16-17
Background: The introduction of BTK inhibitors to the B-cell malignancy space has been a significant advance in convenience and control for patients compared to than seen with intravenous therapy. However, they also pose new clinical challenges relat
Publikováno v:
Journal of Clinical Oncology. 39:e23010-e23010
e23010 Background: About a third of ovarian cancer patients in the US have limited access to a gynecologic oncologist (GO) due to geographic disparities. A survey by The Society of Gynecologic Oncology (SGO) found that the majority of GOs found it wa
Publikováno v:
Journal of Clinical Oncology. 39:e23001-e23001
e23001 Background: The rapid and robust emergence of the immunotherapy era in bladder cancer has prompted a paradigmatic shift in both early and late-stage bladder cancer management. Given this change, it is imperative that members of the bladder can
Publikováno v:
Journal of Clinical Oncology. 38:11021-11021
11021 Background: Advancing the fight against cancer involves many types of research across different disciplines and professions, from PhD-trained scientists to medical oncology physicians. The IOYIF is a competitive academic research program where
Publikováno v:
Journal of Clinical Oncology. 38:11035-11035
11035 Background: Rapid advancements in genomics and sequencing technologies have presented a growing need for experts in the field of genetics to translate results and optimize patient care. As knowledge regarding DNA mutations and the technology to